CREJ2
Mexico·Clase I·III. DIAGNOSTIC AGENTS·PRODUCTOS ROCHE, S.A. DE C.V.·Registered August 13, 2019PRUEBA IN VITRO PARA LA DETERMINACIÓN CUANTITATIVA DE LA CREATININA EN SUERO, PLASMA Y ORINA HUMANOS EN LOS SISTEMAS ROCHE. AGENTE DE DIAGNÓSTICO PARA USO IN VITRO. PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETES
IN VITRO TEST FOR THE QUANTITATIVE DETERMINATION OF CREATININE IN HUMAN SERUM, PLASMA AND URINE IN ROCHE SYSTEMS. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR USE IN CLINICAL OR CABINET LABORATORIES ONLY
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA LA DETERMINACIÓN DE LA CREATININA.
- Trade Name (English)
- TEST FOR THE DETERMINATION OF CREATININE.
- Analysis ID
- 1609R2019 SSA
- Registration Date
- August 13, 2019
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for CREJ2 (CREJ2) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1609R2019 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on August 13, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.